Joshua R. Disbrow

CIK 1566240 · Chief Executive Officer · last filed 2026-03-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$445.5K

Companies

3

Total Filings

38

Lifetime Open-Market Net

$432.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AYTU Chief Executive Officer 207,203 $2.15 $445.5K $373.8K 17 2025-10-07
ZYNEX INC (ZYXI) Delisted Director 22,500 $0.13 $2.9K $58.2K 7 2025-05-16
Ampio Pharmaceuticals, Inc. (AMPE) Delisted Chief Operating Officer $0.18 $0 2 2013-11-27

Recent Filings · Page 4 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-09-02 Buy (P) $0
2016-08-04 Grant (A) +52,374 $0
2016-07-11 Mixed +190,000 $0
2016-05-16 Buy (P) +250,000 $100.0K
2016-01-21 Buy (P) +153,846 $100.0K
2015-11-13 Grant (A) $0
2013-11-27 Ampio Pharmaceuticals, Inc. (AMPE) Delisted Grant (A) $0 EDGAR
2013-01-08 Ampio Pharmaceuticals, Inc. (AMPE) Delisted Grant (A) $0 EDGAR
Showing 3138 of 38
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.